Lumida
/JBIO
⌘K
Jade Biosciences Inc

Jade Biosciences Inc

JBIO
$20.86USD+1.86%+0.38 today

MARKET CAP

1.3B

P/E (TTM)

FWD P/E

DAY RANGE

$19 – $21

52W RANGE

$7
$28

AI Summary

Stalk
StalkMedium

JBIO remains in a Stage 2 advancing phase within its long-term uptrend, supported by Lockout Rally and Higher Highs & Higher Lows patterns. However, price is currently slipping below the short-term EMAs and the rising 50 DMA, showing sideways indecision and neutral momentum. With RSI and Options Score in mid-range and no clear exhaustion or breakout, execution readiness remains neutral, so buy-side engagement is deferred. Watch for a pullback into the EMAs or 50 DMA and subsequent acceptance before initiating new long positions.

  • Stock surged 69% over last 30 days, breaking above its 50-day moving average.
  • 10 Wall Street analysts rate JBIO “Buy,” led by a $45 UBS price target.
  • Negative profitability and low earnings yield question cash-flow potential.
Full analysis →
Insider Trades1 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
May 16, 2025BuyJBIOTom FrohlichChief Executive Officer6,000$7.40$1.3B-25.50%+212.74%$44.4KStalk